Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Herstatin stimulates apoptosis in human small cell lung carcinoma cells

Nov. 26, 2003

NSC-703786 induces single-strand breaks and DNA-protein crosslinks in breast cancer cells

Nov. 26, 2003

PPI-2458 inhibits primary tumor growth in mouse model of melanoma

Nov. 26, 2003

Increased antitumor activity with new formulations of Panzem

Nov. 26, 2003

Plexxikon and Phenomix to develop novel drugs for oncology and inflammation

Nov. 26, 2003

New hypoxic cytotoxin shows promising in vitro and in vivo activity

Nov. 25, 2003

Antitumor activity of MLN-944 due to inhibition of DNA and RNA synthesis

Nov. 25, 2003

New FTase inhibitors in early development at Janssen

Nov. 25, 2003

Enzon enters collaborative development program with NIH for SS1P

Nov. 25, 2003

Metastatic melanoma as a potential new indication for arsenic trioxide

Nov. 25, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...